Invesco Ltd. raised its position in Maximus, Inc. (NYSE:MMS - Free Report) by 19.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 250,594 shares of the health services provider's stock after buying an additional 41,019 shares during the quarter. Invesco Ltd. owned about 0.44% of Maximus worth $18,707,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Norges Bank bought a new stake in Maximus in the 4th quarter valued at about $71,443,000. Federated Hermes Inc. raised its position in shares of Maximus by 74.8% in the fourth quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after purchasing an additional 377,705 shares during the period. Vanguard Group Inc. raised its position in shares of Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after purchasing an additional 205,564 shares during the period. Reinhart Partners LLC. lifted its stake in shares of Maximus by 43.5% during the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider's stock valued at $41,143,000 after buying an additional 167,019 shares in the last quarter. Finally, Ruffer LLP bought a new position in Maximus in the 4th quarter worth approximately $10,266,000. Hedge funds and other institutional investors own 97.21% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.
Check Out Our Latest Analysis on MMS
Maximus Price Performance
Shares of MMS stock traded up $0.27 during trading hours on Thursday, reaching $68.58. The stock had a trading volume of 35,997 shares, compared to its average volume of 549,698. The stock's fifty day simple moving average is $67.63 and its 200 day simple moving average is $74.92. The firm has a market capitalization of $3.88 billion, a PE ratio of 14.73 and a beta of 0.68. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.75%. Maximus's dividend payout ratio is currently 25.81%.
Insider Buying and Selling at Maximus
In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
